The Nasal Polyps Treatment Market: Global Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2028

 

Nasal polyps are benign growths that form inside the paranasal sinuses and the nose lining. It is commonly described as teardrop-shaped and golden brown or pink in color. The size of the polyps can vary, and they might grow in clusters or alone. These can result in serious infections and respiratory difficulties, which can lead to sleep apnea in some situations. Nasal polyps can be caused by asthma, allergy diseases, sinus infections, cystic fibrosis, and other conditions. There are no specific symptoms, however, an inflammation of the nasal lining may arise.

Nasal Polyps Treatment Market is frequently the first course of treatment for nasal polyps. These drugs, which are administered via nasal drops, sprays, nebulizers, and inhalers, reduce inflammation and shorten nasal airways.

Increasing regulatory approvals for nasal polyps treatment are projected to fuel the worldwide nasal polyps treatment market growth. For example, in June 2019, the U.S. Food and Drug Administration (FDA) approved Dupixent for the treatment of nasal polyps. Sanofi produced it in collaboration with Regeneron Pharmaceuticals Inc. It is the first medication for chronic rhinosinusitis with nasal polyps to be licensed. It is used when oral steroids fail to manage the inflammation and surgery is not an option. As a result, such approvals are projected to boost the growth of the worldwide Nasal Polyps Treatment Market.

Nasal polyps are harmless, painless growths on the nasal lining tubes or the sinuses. They frequently dangle down in the shape of grapes or teardrops. They are caused by persistent inflammation and are commonly associated with asthma, allergies, repeated infections, certain immunological disorders, and medication sensitivity. Smaller nasal polyps cause no symptoms, but larger polyps can clog an individual's nasal passages, causing breathing problems, loss of smell, and repeated infections. Nasal Polyps Treatment Market can occur at any age, but they are more common in adults. This disorder's medicine mostly decreases nasal polyps. Nasal polyp surgery must involve the excision of the polyps. 

Key Players in the Global Nasal Polyps Treatment Market

Intersect ENT Inc., GlaxoSmithKline Plc, Merck Sharp and Dohme Corp, Teva Branded Pharmaceutical Products R and D Inc., Norton Waterford Ltd, Sanofi, Regeneron Pharmaceuticals Inc., Fougera Pharmaceuticals Inc., Glenmark, and Taro Pharmaceuticals Industries Ltd are some of the major players in the global nasal polyps treatment market.